Search

everythinglearnresearchcommunity

for

Search:↓

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

The document concludes that "Dictamnus" has a rich cultural history and potential as a herbal medicine, warranting more research into its effects and safety.

PCOS increases sexual pain distress in infertile women.

Most 46XX CAH patients have female identity, but a few identify as male and may need treatment and surgery.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

Different types of androgens bind differently to two receptors, AR1 and AR2, in Atlantic croaker's brain and ovarian tissues, suggesting these receptors may control different androgen actions in fish.

Androgens in female meerkats influence aggression and dominance, affecting social dynamics and offspring behavior.

Siblings with signs of virilization should be tested for non-classical congenital adrenal hyperplasia, which does not affect adult height but may impact fertility and well-being if untreated.

Antiandrogens can treat female hormonal conditions, but environmental ones may harm reproductive health.

The document lists various dermatology topics, treatments, and diagnostic methods.

Vitiligo is a skin condition causing white spots, more common in women, often starts before age 20, and can affect mental health.

Anabolic steroids can build muscle and strength but have risks and need more research on their clinical benefits and side effects.

Estrogens can improve skin aging but carry risks; more research is needed on safer treatments.

Finasteride and minoxidil are effective for hair regrowth, while treatments for alopecia areata have varying success and continuous treatment is necessary.

Lignans and neolignans from plants may help protect against various health issues, including cancer and heart disease.

Hormones significantly affect hair and oil gland function in the skin, and more research is needed on skin-related hormone disorders.

Skin changes can help diagnose and manage endocrine disorders like thyroid problems, diabetes, and adrenal gland conditions.

Men taking 5α-reductase inhibitors for enlarged prostate have a higher chance of experiencing reduced sexual desire and erectile dysfunction.

Different women's hair and skin glands respond to hormones in varied ways, which can cause unwanted hair growth even with normal hormone levels, and more research is needed to treat this effectively.

Antiandrogen treatments combined with oral contraceptives can help manage hair growth and hair loss in women with PCOS.

Lifestyle changes are the main treatment for PCOS, which is a complex condition requiring early management to reduce its health impacts.

People with atopic dermatitis are more likely to develop other skin conditions due to shared genetics and immune pathways.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

New treatments targeting skin stem cells show promise for skin repair, anti-aging, and cancer therapy.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

FOXN1 mutations can cause varying immune and physical issues, with severity influenced by gene activity and possibly other factors.

Dutasteride protects dopamine neurons in Parkinson's mice, but Finasteride doesn't.

Intralesional therapy for keratoacanthoma is effective and has fewer side effects than systemic treatments.

The meeting focused on understanding, diagnosing, and finding treatments for irreversible hair loss diseases.